Pharma, health and science writer at Reuters. Any opinions are mine.

New GSK shingles vaccine may challenge Merck after strong test data

news.yahoo.com — By Ben Hirschler LONDON (Reuters) - An experimental shingles vaccine from GlaxoSmithKline has produced impressive results in a late-stage study, giving the group's expanding vaccine unit a potential $1 billion boost. The data suggests the British company's new shot could be a strong competitor for Merck & Co's established vaccine Zostavax, which is currently the only product on the market.

UPDATE 3-Double blow for Roche as breast cancer, Alzheimer's studies fail

mobile.reuters.com — UPDATE 3-Double blow for Roche as breast cancer, Alzheimer's studies fail * Breast cancer study fails to prove added Kadcyla benefit * Ending Phase III trial with Alzheimer's drug gantenerumab * Roche shares fall 5.4 percent, most in five years * MorphoSys down 9.3 pct, ImmunoGen off 27 pct in premarket (Adds latest shares, more reaction, Breakingviews link) By Silke Koltrowitz and Ben Hirschler ZURICH/LONDON, Dec 19 (Reuters) - Roche suffered a double blow on Friday as two clinical studies of drugs for breast cancer and Alzheimer's disease failed, sparking the biggest percentage fall in its stock in five years.

3D Printing Points Way to Smarter Cancer Treatment

Double blow for Roche as breast cancer, Alzheimer's studies fail

reuters.com — Credit: Reuters/Arnd Wiegmann The logo of Swiss pharmaceutical company Roche is seen at a plant in the central Swiss village of Rotkreuz November 6, 2013. The company also said a late-stage study in people with previously untreated advanced HER2-positive breast cancer showed three of its treatments helped people live without their disease worsening, meeting its non-inferiority endpoint.

3D printing points way to smarter cancer treatment

livemint.com — The initiative is the latest example of medicine harnessing the rapidly emerging 3D printing technology, which has already been used to manufacture some medical implants. Photo: AP London: British scientists have developed a new use for 3D printing, putting it to work to create personalized replica models of cancerous parts of the body to allow doctors to target tumours more precisely.

3D printing helps doctors fine-tune cancer treatment

bdlive.co.za — LONDON - British scientists have developed a new use for 3D printing, putting it to work to create personalised replica models of cancerous parts of the body to allow doctors to target tumours more precisely. The initiative is the latest example of medicine harnessing the rapidly emerging technology, which has already been used to manufacture some medical implants.

New GSK shingles vaccine may challenge Merck after strong test data

reuters.com — Credit: Reuters/Luke MacGregor A British Airways airplane flies past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. The data suggests the British company's new shot could be a strong competitor for Merck & Co's established vaccine Zostavax, which is currently the only product on the market.

EU's top court opens door to some stem cell patents

reuters.com — Credit: Reuters/Yves Herman A piece of a three-dimensional bone structure obtained from the own adipose stem cells of a patient is seen at Brussels' Saint Luc Hospital January 14, 2014. Thursday's judgment by the European Court of Justice was made following a case brought in Britain by U.S.

Particle-smasher to resume work

dispatch.com — GENEVA - The Large Hadron Collider will be turned back on in March and a few weeks later will start smashing subatomic particles together again at nearly double its previous power, helping scientists hunt for clues about the universe.

Funds set aside for Ebola vaccine

bdlive.co.za — LONDON/GENEVA - GAVI, the global vaccines alliance, said on Thursday that it was committing up to $300m to buy Ebola vaccines, as one experimental shot hit a snag in a Swiss clinical trial after some subjects reported joint pains.
More Articles →
Dec 18, 2014

What are you going to do with your extra 6 years? Global #population living longer than in 1990, study finds reut.rs/13zLVQq



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Ben Hirschler, email reutersbenhir@muckrack.com.


Share This Profile